Cancer Clinical Trial - SQZ Biotechnologies - SQZ-PBMC-HPV-101
Cancer
Status:
OpenClinicalTrials.gov:
NCT04084951CONDITION(S): Advanced Solid Tumors - TRIAL: SQZ Biotechnologies SQZ-PBMC-HPV-101-Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
This is a Phase 1 open-label, multicenter study of the safety and tolerability, immunogenic effects, antitumor activity, and pharmacodynamics of SQZ-PBMC-HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ patients with recurrent, locally advanced or metastatic human papillomavirus strain 16 positive (HPV16+) solid tumors.